# A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels

> **NCT00749385** · PHASE1 · COMPLETED · sponsor: **POZEN** · enrollment: 40 (actual)

## Conditions studied

- Arthritis

## Interventions

- **DRUG:** PN 400
- **DRUG:** EC naproxen plus EC esomeprazole
- **DRUG:** EC naproxen
- **DRUG:** EC esomeprazole

## Key facts

- **NCT ID:** NCT00749385
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749385, "A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00749385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*